文献速递疼痛医学区域麻醉与超声

超声引导经皮冷冻神经松解术治疗慢性截肢后幻肢痛:多中心随机对照试验

Ultrasound-guided Percutaneous Cryoneurolysis to Treat Chronic Postamputation Phantom Limb Pain: A Multicenter Randomized Controlled Trial.
PubMed 文献 · Anesthesiology · 2023-01-01

该多中心随机对照试验纳入下肢截肢后幻肢痛患者,比较超声引导经皮冷冻神经松解术与假治疗的效果。主要结局为基线至4个月平均幻肢痛强度变化,结果显示冷冻神经松解组疼痛下降0.5,假治疗组下降0,组间估计差异-0.1(95%CI -1.0至0.7,P=0.759),未显示疗效。

要点

  • 单次冷冻神经松解术未降低慢性下肢幻肢痛4个月时的疼痛强度。
  • 研究按统计门控方案未对次要终点进行推断或得出结论。
  • 一例严重不良事件因方案偏差导致股四头肌无力,可能跌倒并锁骨骨折。

核心结论

  • 经皮冷冻神经松解术未在治疗4个月后降低慢性下肢幻肢痛。
  • 作者指出其研究方案特定,最佳冷冻参数如冷冻时长和解剖治疗位置仍未知,需进一步研究。

研究设计与样本

  • 多中心随机对照试验,纳入下肢截肢且幻肢痛已确立的患者。
  • 所有患者先接受利多卡因股神经和坐骨神经单次注射阻滞,随后随机接受超声引导经皮冷冻神经松解术或相同部位的假治疗。
  • 主要结局为基线至4个月平均幻肢痛强度(数字评定量表0至10)的变化,之后提供可选交叉治疗。
  • 对研究者、参与者和临床工作人员设盲,但执行冷冻神经松解术的治疗医师除外,该医师随后不与参与者互动。

主要发现

  • 治疗前幻肢痛评分两组相似,活动治疗组中位数[四分位数]为5.0[4.0, 6.0],假治疗组为5.0[4.0, 7.0]。
  • 4个月后,冷冻神经松解组(n=71)疼痛强度下降0.5[-0.5, 3.0],假治疗组(n=73)下降0[0, 3]。
  • 组间估计差异(95%CI)为-0.1(-1.0至0.7),P=0.759。
  • 按统计门控方案,作者未对次要终点进行推断或得出结论。
  • 一例严重不良事件发生在方案偏差后,即在腹股沟韧带下方诱导股神经冷冻损伤而非仅感觉隐神经,导致股四头肌无力,可能跌倒并锁骨骨折。

临床怎么用

  • 根据本试验结果,经皮冷冻神经松解术不应被常规用于治疗慢性下肢幻肢痛。
  • 操作时需注意避免偏离方案损伤运动神经,本试验中股神经冷冻损伤导致股四头肌无力及可能跌倒。

局限性

  • 作者指出最佳冷冻神经松解治疗参数如冷冻时长和解剖治疗位置仍未知。
  • 结果基于作者特定的研究方案,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postamputation phantom pain is notoriously persistent with few validated treatments. Cryoneurolysis involves the application of low temperatures to reversibly ablate peripheral nerves. The authors tested the hypothesis that a single cryoneurolysis treatment would decrease phantom pain 4 months later. METHODS: The authors enrolled patients with a lower-limb amputation and established phantom pain. Each received a single-injection femoral and sciatic nerve block with lidocaine and was subsequently randomized to receive either ultrasound-guided percutaneous cryoneurolysis or sham treatment at these same locations. The primary outcome was the change in average phantom pain intensity between baseline and 4 months as measured with a numeric rating scale (0 to 10), after which an optional crossover treatment was offered. Investigators, participants, and clinical staff were masked to treatment group assignment with the exception of the treating physician performing the cryoneurolysis, who had no subsequent participant interaction. RESULTS: Pretreatment phantom pain scores were similar in both groups, with a median [quartiles] of 5.0 [4.0, 6.0] for active treatment and 5.0 [4.0, 7.0] for sham. After 4 months, pain intensity decreased by 0.5 [-0.5, 3.0] in patients given cryoneurolysis (n = 71) versus 0 [0, 3] in patients given sham (n = 73), with an estimated difference (95% CI) of -0.1 (-1.0 to 0.7), P = 0.759. Following their statistical gatekeeping protocol, the authors did not make inferences or draw conclusions on secondary endpoints. One serious adverse event occurred after a protocol deviation in which a femoral nerve cryolesion was induced just below the inguinal ligament-instead of the sensory-only saphenous nerve-which resulted in quadriceps weakness, and possibly a fall and clavicle fracture. CONCLUSIONS: Percutaneous cryoneurolysis did not decrease chronic lower extremity phantom limb pain 4 months after treatment. However, these results were based upon the authors' specific study protocol, and since the optimal cryoneurolysis treatment parameters such as freeze duration and anatomic treatment location remain unknown, further research is warranted.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Ilfeld BM, Smith CR, Turan A, et al. Ultrasound-guided Percutaneous Cryoneurolysis to Treat Chronic Postamputation Phantom Limb Pain: A Multicenter Randomized Controlled Trial. Anesthesiology. 2023. PMID: 36512721. doi:10.1097/ALN.0000000000004429

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。